The Assisted Reproductive Technology Market is expanding due to rising infertility rates, delayed pregnancies, lifestyle changes, and advancements in fertility treatments. Valued at USD 25.07 Billion in 2025, the market is projected to reach USD 47.06 Billion by 2035, growing at a CAGR of 6.50% from 2026 to 2035.

Increasing awareness about fertility preservation, higher maternal age, and growing acceptance of assisted conception methods are major factors supporting demand. Technological innovations in embryo freezing, genetic screening, and lab automation are also enhancing treatment success rates, further accelerating market growth globally.

How Large Will the Assisted Reproductive Technology Market Be by 2035?

By 2035, the Assisted Reproductive Technology Market is expected to reach USD 47.06 Billion, driven by increasing fertility clinic networks and medical tourism. Regions such as North America, Europe, and Asia Pacific dominate due to advanced healthcare systems and supportive regulatory frameworks.

Rising adoption of frozen embryo replacement (FER), surrogacy services, and ovulation induction therapies are significantly contributing to market expansion.

Market Segmentation by Type and Product

By type, the market includes In-Vitro Fertilization (IVF) and Artificial Insemination. IVF remains the dominant segment, further categorized into fresh donor, frozen donor, fresh non-donor, and frozen non-donor cycles. Artificial insemination includes intrauterine, intracervical, intravaginal, and intratubal insemination.

Based on product, the market is segmented into instruments, accessories & disposables, and reagents & media. Reagents and media account for a substantial share due to their continuous usage in fertility procedures.

Request sample Report Explore

Age, Application, and End-User Insights

Women older than age 35 represent a growing patient segment due to delayed parenthood trends. Key applications include frozen embryo replacement (FER), surrogacy, ovulation induction, and others.

Fertility clinics and specialized centers dominate the end-user segment, while hospitals also play a crucial role in providing advanced reproductive services.

Regional and Competitive Landscape

North America leads the market, followed by Europe and Asia Pacific. Latin America and the Middle East & Africa are emerging markets with rising fertility treatment awareness.

Key players include Microm U.K. Ltd., CooperSurgical, Inc., FUJIFILM Irvine Scientific, Cyprus IVF Centre, Vita Altera IVF Center, Cryolab Ltd., Vitrolife AB, European Sperm Bank, Bloom IVF Centre, and Merck KGaA.